To the Editor: I read with interest the article by Dr Ross and colleagues1 on ghost authorship and guest authorship of original articles and reviews relating to rofecoxib that were presumably supported by Merck. I deplore the practice of ghost or guest authorship. I was dismayed, however, to note inclusion of a review2 that I coauthored in a table of articles that were implicitly tainted in this respect. A footnote indicates that the reason for inclusion was mention of one (or both) of the academic authors in Merck internal correspondence. The implication that the content of this article was in any way sponsored, influenced, previewed, or written by Merck is entirely incorrect.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 1
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.